TNRC6C Functions as a Tumor Suppressor and Is Frequently Downregulated in Papillary Thyroid Cancer

Table 2

The association of TNRC6C expression with clinicopathological features of PTC in TCGA database.

Clinicopathological features	TNRC6C expression level		value
	Low	High
Age
≤46	110	142	0.004
>46	141	109
Gender
Female	191	176	0.131
Male	60	75
T classification
T1	67	76	0.002
T2	68	96
T3	98	72
T4	17	6
N classification
N0	101	128	0.014
N1	124	99
M classification
M0	136	146	0.178
M1	2	7
Clinical stage
I	127	154	0.005
II	22	30
III	66	46
IV	36	19
Histological type
Classical/follicular	213	244	<0.001
Tall cell	32	4
Focality
Unifocal	140	126	0.243
Multifocal	107	119

Age and TNRC6C expression level were divided into two groups according to the median.